Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 1:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 4,268 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ADM Clear all

Conditions: Multiple Chronic Conditions, Decision Making, Shared
Interventions: Patient Priorities Care, Usual Care; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 65 Years and older
Enrollment: 437 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: West Haven, Connecticut • Houston, Texas

Conditions: Ovarian Cancer, Peritoneal Cavity Cancer
Interventions: carboplatin, pegylated liposomal doxorubicin hydrochloride; Drug
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2011
U.S. locations: 91
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 59 more

Conditions: Low Back Pain
Interventions: Core Stabilization, Trunk Motion and Fitness; Other
Lead sponsor: Drexel University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • West Chester, Pennsylvania

Conditions: Peripheral Arterial Disease, Peripheral Vascular Disease, Artery Disease, Peripheral, Femoropopliteal Artery Occlusion
Interventions: Surmodics SurVeil DCB, Medtronic IN.PACT Admiral DCB; Device
Lead sponsor: SurModics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 446 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 50
States / cities: Birmingham, Alabama • Foley, Alabama • Gilbert, Arizona + 45 more

Conditions: PTSD
Interventions: RESCUE, Prolonged Exposure; Behavioral
Lead sponsor: Charleston Research Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Gynecological Surgery
Interventions: Not listed
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Hepatocellular Carcinoma
Interventions: ThermoDox, Dummy infusion; Drug
Lead sponsor: Imunon; Industry
Eligibility: 18 Years and older
Enrollment: 554 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Traumatic Brain Injury, Self Efficacy
Interventions: BICS Q; Diagnostic Test
Lead sponsor: Rehabilitation Hospital of Indiana; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Non-traumatic and Traumatic Orthopaedic Issues
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: General Anesthesia
Interventions: study cases; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Early Onset Alzheimer Disease, Mild Cognitive Impairment, Depression, Aging
Interventions: Not listed
Lead sponsor: ElMindA Ltd; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: The Villages, Florida

Conditions: End Stage Liver Disease
Interventions: Advance Care Planning Video Decision Support Tool, Verbal Narrative; Behavioral · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Laryngeal Masks
Interventions: air-Q SP, air-Q, i-gel; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Ovarian Cancer, Epithelial Ovarian Cancer, Pancreatic Adenocarcinoma
Interventions: Prehabilitation; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 65 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma
Interventions: Cisplatin, Doxorubicin, Methotrexate, Pegfilgrastim, Pembrolizumab, Radical Cystectomy, Vinblastine Sulfate; Drug · Biological · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Colorectal Cancer, Metastatic Cancer
Interventions: FOLFIRI regimen, cisplatin, doxorubicin hydrochloride, fluorouracil, irinotecan hydrochloride, leucovorin calcium, mitomycin C; Drug
Lead sponsor: American College of Radiology Imaging Network; Network
Eligibility: 18 Years to 120 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2002
U.S. locations: 9
States / cities: Tucson, Arizona • Tampa, Florida • Chicago, Illinois + 6 more

Conditions: Substance Abuse, Contingency Management, Exercise
Interventions: Contingency Management; Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Alcohol-induced Disorders, Drug Users, Tobacco Use Disorder
Interventions: The brief interventions are delivered by behavioral health counselors (Specialist), The brief interventions are delivered by the primary care provider (Generalist); Behavioral
Lead sponsor: Friends Research Institute, Inc.; Other
Eligibility: 18 Years to 99 Years
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: DLBCL
Interventions: Rituximab Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Implementation, Behavioral Symptoms
Interventions: Leadership for Organization Change and Implementation (LOCI), Training and Technical Assistance Only; Behavioral
Lead sponsor: Boise State University; Other
Eligibility: 4 Years and older
Enrollment: 686 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 4
States / cities: San Diego, California • Orlando, Florida • Boise, Idaho + 1 more

Conditions: Lymphoma
Interventions: bleomycin sulfate, carmustine, cyclophosphamide, dacarbazine, doxorubicin hydrochloride, etoposide, vinblastine, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 15 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2005
U.S. locations: 47
States / cities: Birmingham, Alabama • La Jolla, California • San Francisco, California + 29 more

Conditions: Cholecystectomy
Interventions: Regular Hours, After Hours, Robotic-assisted Cholecystectomy; Procedure · Device
Lead sponsor: Intuitive Surgical; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 505 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Bone Injuries, Muscle Injuries, Tendon Injuries
Interventions: Ultrasound Scan, Ultrasound Scan using a General Electric Ultrasound Scanner Model Logiq E9 (model name).; Procedure · Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Diffuse Large B-Cell Lymphoma
Interventions: Loncastuximab tesirine, Prednisone, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine; Drug
Lead sponsor: ADC Therapeutics S.A.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Effect of Patient Priorities Care Implementation in Older Veterans With Multiple Chronic Conditions

S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer

Recurrent Low Back Pain: Linking Mechanism to Outcomes (RCT)

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD

Plethysmography Variability Index as an Indicator of Adequacy of Preload

Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

Brain Injury Self-Efficacy Scale Validation

Orthopaedic Hand and Upper Extremity Data Repository

Intraoperative M-Entropy Measurements

Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain

A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease

Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Reinforcing Exercise in Substance Abusing Patients

SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers

A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma

Working to Implement and Sustain Digital Outcome Measures

S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease

Study of Peri-operative and Acute Outcomes After Robotic-assisted Cholecystectomy

Impact of Volume Imaging Using Diagnostic Ultrasound

A Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8)